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INTRODUCTION
Morinda citrifolia, which is locally known 
as “mengkudu”, has various names such as 
“noni” in Hawaii, “Indian mulberry” in Indian 
subcontinent, “painkiller bush” in the Caribbean 
and “cheese fruit” in Australia (Nelson, 2001; 
Ross, 2001; Wang et al., 2002).  The plant has 
been used for food and medicinal purposes by 
Polynesians for more than 2000 years (Chan-
Blanco et al., 2006).  It has also been reported 
to have assorted therapeutic effects in both 
human and laboratory animals (Wang et al., 
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ABSTRACT
A subchronic oral toxicity study was conducted to evaluate the safety of Morinda citrifolia in Sprague-Dawley 
(SD) rats.  For this purpose, the fruit of Morinda citrifolia were oven dried and ground into powder form 
before incorporating into diet and fed to SD rats (10 males and 10 females per group) at dose levels of 2000 
(low dose) and 5000 (high dose) mg/kg body weight/day for 13 weeks.  Clinical observations were recorded, 
while body weight and feed consumption were measured throughout the study.  At the end of the study, all 
the rats were subjected to a full necropsy.  Their blood samples were collected for clinical pathology, whereas 
selected organs were weighed and tissues were preserved from all the animals.  Total protein was found to be 
significantly lower (p<0.05) in male rats of all the treatment groups.  Meanwhile, total white blood cells (3.96 
×10³/µl) and spleen weight (0.14%) were found to be significantly lower (p<0.05) in female rats of the low 
dose group.  Nevertheless, the differences observed were within the normal range of normal healthy rats that 
were considered to be not toxicological significance.  It was concluded that the no-observed-adverse-effect 
level (NOAEL) for Morinda citrifolia was 5000 mg/kg body weight/day.
Keywords: Morinda citrifolia, oven dried, subchronic, rats, clinical pathology
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2002).  In view of the large number of medical 
claims that have been made for its efficacy, the 
most important thing not to be overlooked for 
Morinda citrifolia is the safety aspect of the 
plant, especially the fruit.
Morinda citrifolia product, such as the juice, 
is increasingly popular as a functional drink 
due to the claim indicating its benefits for many 
illnesses.  Since 1996, worldwide production of 
noni fruit juice has tremendously increased with 
more than 80 million litres by French Polynesia 
alone (European Food Safety Authority, 2006). 
The increase in the consumption of noni fruit 
juice has brought about the concern over 
its safety in people who have been drinking 
the noni fruit juice product.  Thus, various 
toxicological studies have extensively been 
carried out on the fruit juice (Tahitian Noni) 
and it has been reported to be safe by Scantox 
Biologisk Laboratorioum, Lille, Skensved, 
Denmark March 2000 and May 2001 (West et 
al., 2006); however, there were reported cases 
of the toxicity, especially liver toxicity.  In the 
period between 2004 and 2006, there were 
reported cases published whereby the noni fruit 
juice was suggested to have been responsible for 
acute hepatitis (Millonig et al., 2005; Staldbauer 
et al., 2005; Yüce et al., 2006).
Meanwhile, it is important to note that 
toxicological evaluation is a need in herbal 
studies.  The health promoting benefits of 
Morinda citrifolia have been known for 
generations and they are extensively used in 
many countries for its medicinal properties. 
The increasing use of this plant has resulted 
in concerns over both the efficacy and safety 
of the product.  Despite the widespread use 
of Morinda citrifolia in Malaysian traditional 
medicine, a survey of the literature has indicated 
a lack of proper toxicological evaluation of 
these local varieties.  Due to the high promising 
and commercial potential of Morinda citrifolia 
products, it is therefore essential that Morinda 
citrifolia be studied for possible toxicity.  It 
is particularly important in detecting toxicity 
that occurs either after a short period or after 
a prolonged exposure to Morinda citrifolia. 
Hence, through the toxicity studies in animals, it 
is anticipated that it can be viewed to safeguard 
the public health and ensure greater value for 
money of the herbal product during normal 
conditions of use.  The toxicity studies have 
also provided a preclinical safety evaluation 
standard that is expected to be performed 
before Morinda citrifolia can be evaluated in 
human.  The subchronic oral toxicity study of 
Morinda citrifolia was performed in Sprague-
Dawley (SD) rats to provide benchmark data 
so as to understand its safety without the 
potential confounding variables associated with 
many commercial Morinda citrifolia products. 
This study was therefore carried out with the 
objectives to investigate the safety of Morinda 
citrifolia through a 13-week subchronic toxicity 
study in the male and female Sprague Dawley 
rats, as well as to determine the no-observe-
adverse-effect level (NOAEL) of Morinda 
citrifolia in rats fed at the doses of 2000 mg/kg 
and 5000 mg/kg body weight.
MATERIALS AND METHODS
Test Material
Fresh fruits of Morinda citrifolia were obtained 
from MARDI Research Station, located in 
Muadzam Shah, Pahang.  The fruit samples were 
finely sliced into 8 mm in thickness and dried in 
an oven at 55 - 60 °C for 48 hours.  The samples 
were then ground into powder, followed by 
incorporating it into commercial rodent diet that 
had previously been ground before the mixing 
process.  Finally, the combination of dried fruit 
samples and commercial rodent diets were given 
as treatment diets for the toxicity trial.  The 
treatment diets were freshly prepared every week 
according to the body weight of the rats.
Animals Management
Sixty male and female Sprague-Dawley (SD) 
rats at 6 weeks of age, with an average body 
weight of 170 - 200 grams, were used in the 
study.  The rats were acclimatized to the housing 
conditions for a period of 1 week, and the 
treatment started at the age of 7 weeks.  All the 
rats were individually housed in a polycarbonate 
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mesh bottom cage during the acclimatization 
period and, were thereafter kept in a room 
maintained at a temperature of 25–27°C and a 
relative humidity of 40–70% with a 12-h light/
dark cycle.  Each cage was provided with a 
colour-coded card containing rat number and 
for dose level identification.
Experimental Design
The rats were weighed and randomly assigned 
into three groups (10 males and 10 females per 
group), namely, control, low dose and high dose 
according to the randomized complete block 
design (RCBD).  When placed in the study, 
the average weights of the female and male 
rats were around 170-190 and 220-240 grams, 
respectively.  The powdered Morinda citrifolia 
fruit were incorporated into the treatment diets 
at the dose levels of 2000 and 5000 mg/kg body 
weight/ day for 13 weeks.  Meanwhile, the 
control group received commercial rodent diet 
only.  Feed were given ad libitum and all rats had 
free access to water.  The amounts of supplied 
and residual diet were weighed twice a week (at 
days 6 and 7) in order to calculate the daily feed 
consumption.  The rats were observed daily for 
clinical signs and mortality, and were weighed 
weekly.  The animals were let to fast overnight 
prior to necropsy.  At the end of 13 weeks or 91-
day test periods, all the rats were euthanatized 
using overdosed diethyl ether.  Upon necropsy, 
their blood samples were taken via caudal vena 
cava for clinical pathology (clinical biochemistry 
and haematology), while selected organs were 
weighed and specific tissues from all animals 
were preserved for subsequent histopathology 
examination.  The study was conducted at the 
Animal House, Malaysia Agricultural Research 
and Development Institute (MARDI) in Serdang, 
Malaysia, and was complied with the OECD 
Guidelines for the Testing of Chemicals (OECD 
Guidelines 408, 1998).
Clinical Pathology
The serum was analysed for alanine amino 
tranferase (ALT), aspartate amino transferase 
(AST), alkaline phosphatase (ALP), gamma 
glutamyl transferase (GGT), creatinine kinase 
(CK), urea, creatinine, total protein (TP) and 
albumin using automated clinical chemistry 
analyzer (TRX 7010, Biorex Mannheim, 
Germany).  The following haematological 
components were analyzed: total white 
blood cells (WBC), red blood cells (RBC), 
haematocrit/packed cell volume (HCT/PCV), 
haemoglobin (Hb), mean corpuscular volume 
(MCV), mean corpuscular haemoglobin (MCH), 
mean corpuscular haemoglobin concentration 
(MCHC) and platelets, using an automated blood 
analyzer (Cell Dyn® 3700, Abbott Diagnostic, 
USA).
Pathology
The main organs, such as liver, kidney, spleen, 
heart, lungs and testes, were quickly excised for 
all the excess tissues and immediately weighed 
after rinsing them in 0.9% cold saline to remove 
any blood.  The organ relative weight (% of 
body weight) was obtained by dividing the final 
weight of the organ to the final body weight. 
The tissue samples of the liver and kidney were 
routinely processed for histopathology and they 
were examined under light microscope.
Statistical Analysis
The mean values and standard errors were 
calculated from the data obtained, and these were 
then statistically analyzed using SAS version 9.1. 
Meanwhile, Duncan’s multiple range analysis 
was employed to determine the differences in 
the parameters of the two sexes and between the 
treatment groups.
RESULTS
Body Weight
The mean body weights of male and female 
rats for all the treatment groups are shown in 
Figs. 1 and 2.  There was no significant difference 
observed that was attributed to the administration 
of the test substance between sexes.  There was 
no difference between the treatment groups in 
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Fig. 1: The mean body weights of the male rats that were given Morinda citrifolia 
incorporated in their diet for three months
Fig. 2: The mean body weights of the female rats given Morinda citrifolia incorporated 
in their diet for three months
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the male rats throughout the experimental period, 
except at week 2, whereby the body weight was 
significantly (p<0.05) lower in the low dose 
group (Fig. 1).  In female rats, the mean body 
weight was significantly (p<0.05) lower at week 
12 in the high dose group and in both the low 
and high dose groups at week 13, as compared 
to the control (Fig. 2).
Clinical Pathology
Generally, there was no significant difference 
between the sexes in all the parameters measured 
for haematology (Table 1) and biochemistry 
(Table 2).  Some statistically significant 
changes between the treatment groups in certain 
haematology and biochemistry values were 
also noted.  Nevertheless, the magnitudes of 
the changes were not biologically relevant and 
the values were also within the normal range of 
rats of this strain and age.  The white blood cells 
(WBC) count (Table 1) of the females in the low 
dose group were significantly (p<0.05) lower 
compared to the control and high dose groups. 
Meanwhile, the total protein (TP) concentration 
was significantly (p<0.05) lower in the male rats 
as compared to the females in all groups.
Organ Relative Weight
The mean organ relative weights for both the 
male and female rats in all the treatment groups 
are shown in Table 3.  The spleen weight of the 
females in the low dose group were significantly 
(p<0.05) lower as compared to the control and 
high dose groups.
Histopathology
The histopathological examinations of the liver 
and kidney revealed no significant findings 
related to the treatments.
TABLE 1 
The means haematology values of the treatment groups in the male and female rats 
(mean ± S.E.M)
Parameters
Treatment group
Control Low dose High dose
Male Female Male Female Male Female
WBC (×10³/µl) 9.78
± 0.66
5.96a
±  0.58
7.95
± 0.98
3.96b 
± 0.53
8.78
± 0.82
4.82a
± 0.29
RBC (×106/µl) 8.85
± 0.11
7.62
± 0.17
8.90
± 0.19
6.92
± 0.78
8.90
± 0.11
7.59
± 0.15
Hb (g/dl) 16.1
± 0.17
14.4
± 0.24
16.2
± 0.34
12.5
± 1.53
16.1
± 0.14
14.2
± 0.27
HCT (%) 50.0
± 1.24
43.8
± 1.07
46.9
± 0.93
37.4
± 4.23
48.8
± 1.38
43.4
± 0.95
MCH (pg) 18.2
± 0.14
19.0
± 0.15
18.0
± 0.10
23.7
± 6.95
17.9
± 0.22
18.7
± 0.15
MCHC (g/dl) 32.4
± 0.90
33.2
± 0.72
34.6
± 0.23
29.9
± 3.54
33.2
± 0.86
32.9
± 0.14
MCV (fl) 56.6
± 1.56
57.6
± 1.52
52.1
± 0.46
48.7
± 5.55
54.3
± 1.66
57.4
± 1.78
PLT (×10³/µl) 1324
± 25.0
1271
± 30.9
1298
± 40.1
1110
± 42.2
1345
± 29.8
1350
± 43.0
a,b: Means with different superscript/s within the same row differ significantly (p< 0.05)
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DISCUSSION
In the recent years, there has been growing 
interest in the safety of herbal products due 
to a large increase in its consumption as 
dietary supplements, either for enhancing 
health or physical performances.  The use of 
complementary and alternative medicine is 
rapidly increasing in developed countries and in 
many parts of the world, while uses of traditional 
medicine remain widespread in developing 
countries.  In Malaysia, safety information 
with regards to herbs is very limited because 
there is no universal regulatory system that 
ensures the safety of phytopharmaceuticals or 
herbal products (Mohammed, 2006).  Most 
people believe that herbal medicines have no 
side effects or any potential risks due to their 
natural origins and are often considered as food 
supplements, not drugs.  This study focused on 
the herbal plant of Morinda citrifolia (locally 
known as ‘mengkudu’) which has extensively 
been used in many countries for its medicinal 
properties.  A number of in vitro and in vivo 
studies demonstrate a range of potentially 
beneficial effects, such as antioxidant and 
immunomodulatory properties (Olivier & 
Matthias, 2007).  Meanwhile, the increased use 
of this plant has resulted in concerns over both 
the efficacy and safety of the product.
TABLE 2 
The means serum biochemistry values of the treatment groups in the male and female rats 
(mean ± S.E.M)
Parameters
Treatment
Control Low dose High dose
Male Female Male Female Male Female
ALT (U/L) 29.0 
± 0.6
31.2
± 0.3
26.7
± 0.5
30.0
± 0.3
32.7
± 0.7
31.5
± 0.4
AST (U/L) 150.7
± 15.6
149.4
± 15.0
139.2
± 11.6
139.2
± 11.6
132.1
± 6.2
126.1
± 11.8
ALP (U/L) 78.6
± 3.6
63.6
± 9.7
77.4
± 4.2
63.4
± 8.1
89.6
± 7.1
66.5
± 9.5
GGT (U/L) 51.3
± 15.8
23.0
± 7.2
47.9
± 11.7
35.0
± 16.7
67.9
± 21.0
74.5
± 4.6
Creatinine (μmol/L) 24.2
± 15.3
35.9
± 13.4
16.9
± 40.2
31.2
± 12.6
41.5
± 14.6
40.2
± 14.2
Urea (mmol/L) 7.5
± 0.6
6.1
± 0.5
5.7
± 0.5
5.8
± 0.6
6.3
± 0.8
6.2
± 0.3
CK (U/L) 197.3
± 65.1
169.3
± 61.4
249.0
± 68.5
177.0
± 35.1
173.1
± 51.2
131.6
± 9.93
TP (g/L) 64.7b
± 1.3
72.9a
± 1.6
65.2b
± 1.2
74.1a
± 1.2
67.9b
± 2.1
74.5a
± 4.6
Albumin (G/L) 40.8
± 1.2
34.2
± 0.88
37.3
± 4.82
34.9
± 0.43
41.2
± 2.77
35.9
± 1.08
Globulin (G/L) 32.0
± 0.68
30.5
± 0.92
36.8
± 4.93
30.0
± 0.62
33.4
± 1.88
32.1
± 1.18
A/G ratio (G/L) 1.3
± 0.04
1.1
± 0.04
1.2
± 0.16
1.2
± 0.07
1.2
± 0.02
1.2
± 0.05
a,b: Means with different superscript/s within the same row differ significantly (p< 0.05)
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The present study was conducted to evaluate 
the safety use of Morinda citrifolia that was 
incorporated daily in the diet of male and female 
Sprague-Dawley rats.  As indicated earlier, 
no deaths and clinical signs of toxicity were 
observed throughout the experimental period. 
The consumption of Morinda citrifolia was 
tolerated well and did not produce any general 
organ or systemic toxicity when fed to the male 
and female rats at the dose levels of 2000 and 
5000 mg/kg/day.  One of the indicators for the 
health status of the experimental animals is an 
increment in the body weight (Heywood, 1983). 
In this study, all the rats of both sexes in the 
treatment and control groups were increased in 
body weight as they were in the growing stage. 
At the initial stage of the study, the body weights 
of the male rats in the low dose group slightly 
decreased, which could be explained by the 
attempt of the rats in this group to adjust with 
the new diet.  The decrease in the body weight 
of the female rats at the end of the experimental 
period in both the treatment groups as compared 
to the control could not be determined since the 
rats were physically healthy and did not show 
any signs of toxicity.  However, the recorded 
body weights were acceptable for the female 
rats of this strain at this age.  In fact, there were 
no adverse haematologic effects related to the 
treatment doses.  The cause for the lower WBC 
in the females of low dose group could not be 
ascertained since the value was within the normal 
range of rats of this particular strain and age.  In 
general, clinically low WBC could probably 
be due to chronic infection, i.e. either bacterial 
or viral infections.  In this study, significantly 
decreased WBC count was contributed by the 
decrease in lymphocytes (2.47 × 103/µl) [data 
not shown], however these were still within the 
normal range (1.64 – 19.5 × 103/µl) of normal 
healthy rats.  Lymphocytes are a type of white 
blood cell that is responsible for protecting the 
body against bacterial and viral infections.  One 
of the most common causes of clinically low 
WBC is an underlying viral infection which can 
cause a temporary drop in lymphocytes as more 
TABLE 3 
The means organ relative weight of the treatment groups in the male and female rats 
(mean ± S.E.M)
Parameters
Treatment group
Control Low dose High dose
Male Female Male Female Male Female
Body weight 490.4
± 37.4
265.1
± 12.1
454.6
± 14.7
219.1
± 25.2
477.9
± 28.6
248.7
± 6.5
Liver 2.43
± 0.07
2.75
± 0.08
2.57
± 0.08
2.48
± 0.28
2.48
± 0.06
2.77
± 0.10
Kidney 0.56
± 0.01
0.61
± 0.02
0.60
± 0.01
0.54
± 0.06
0.56
± 0.02
0.61
± 0.02 
Lungs 0.41
± 0.03
0.53
± 0.01
0.38
± 0.02
0.47
± 0.05
0.39
±  0.02
0.57
± 0.03
Spleen 0.15
± 0.01
0.18a
± 0.01
0.15
± 0.01
0.14b
± 0.02
0.15
± 0.01
0.19a
± 0.01
Heart 0.26
± 0.01
0.31
± 0.01
0.26
± 0.01
0.32
± 0.03
0.27
± 0.01
0.32
± 0.01
Testis 0.58
± 0.05
n.a 0.53
± 0.04
n.a 0.61
± 0.06
n.a
a,b: Means with different superscript/s within the same row differ significantly (p< 0.05)
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of them are drawn away to fight the infection 
(David, 2000).  Based on the observation made 
throughout the experimental period, all the rats 
were clinically healthy and did not show any 
signs of infection.  No treatment-related changes 
were found in the serum biochemistry of the male 
and female rats in all the groups.  Biochemical 
measurements, indicative of liver injury such as 
ALT, AST, ALP, GGT, and total protein, revealed 
no treatment-related effects.  The periportal area 
of the liver is the first area of the hepatic lobule 
to be exposed to a toxin being delivered via 
the blood (Huxtable, 1988) and there were no 
treatment-related changes of the liver enzymes 
in the male and female rats.  The cause for the 
lower TP in the males of all groups could be 
explained by the physiological fact since the 
values were within the normal ranges (60.0–67.0 
G/L) for healthy male SD rats.  The parameters 
indicative of kidney functions, such as urea and 
creatinine (Moshi et al., 2001) also showed no 
treatment-related effects.  Organ relative weight 
measurement is another important guide to 
assess general toxicity.  In particular, changes 
in the organ weight are indicators of toxicity 
since these will be affected by the suppression 
of the body weight (Heywood, 1983).  Although 
the weight of female spleen in the low dose 
group was significantly lower, the magnitude 
of the difference is rather small and comparable 
to the weight of the male spleen in the control 
and treatment groups, and thus, this cannot be 
considered clinically relevant.  Based on the 
literature review of the phytochemical content 
of Morinda citrifolia, the histopathological 
examination was only done on the liver and 
kidney since these are the two most important 
organs for detoxification process in the body.  The 
histopathological examination was conducted in 
all the animals in the control and high dose 
groups.  In the rats that received high doses 
of Morinda citrifolia, no microscopic lesions 
attributable to the treatment were observed. 
More importantly, the no treatment-related 
changes observed in any of the dose groups for 
the histological examinations demonstrated the 
absence of toxicity to the liver and kidney.
CONCLUSION
In this study, Morinda citrifolia did not show 
any toxicity even when it was fed at a high 
dose of 5000 mg/kg body weight.  The minor 
effects observed in both the males and females 
of the low dose group did not appear to be of 
toxicological significance.  In conclusion, if 
Morinda citrifolia is consumed at the rate of 
5000 mg/kg body weight/day, there is likely 
no chance of developing toxicity, as proven in 
this study.  Therefore, the NOAEL for Morinda 
citrifolia was determined to be greater than 5000 
mg/kg body weight per day.
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